
Cabazitaxel EVER Pharma
xyz
Preparation
10 mg/ml concentrate for, infusion solution, solution for injection.
6 ml vial containing concentrate for infusion solution, solution contains cabazitaxel monohydrate or anhydrous cabazitaxel equivalent to 60 mg cabazitaxel.
Indications
Used in combination with prednisone or prednisolone is indicated for the treatment of adult patients with metastatic castration-resistant prostate cancer.
Storage
No special storage instructions before preparation. Do not freeze.
​
Packaging
One package contains a vial containing concentrate for infusion solution, solution.
-
Package size: 1 x 6 ml (60 mg)
-
Package size: 1x5ml (50mg)
Item number
-
Vnr: 192032 Cabazitaxel EVER Pharma 60 mg
-
Vnr: 483336 Cabazitaxel EVER Pharma 50 mg
​
ATC code
L01CD04
​
For more information:
The page was last updated on 21/09/2020

Note that the appearance of the packaging may differ depending on the country.